Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

Fig. 2

Recovery rate among patients with severe COVID-19 pneumonia. Recovery rate defined as the first day the patient satisfied criterion 6, 7, or 8 of the 8-point ordinal scale. Patients receiving Auxora had a shorter median time to recovery (5 days) than patients treated with standard of care (12 days); recovery rate ratio was 1.87 (95% CI, 0.72 to 4.89). Patients with severe COVID-19 pneumonia were receiving low-flow supplemental oxygen (arm A)

Back to article page
\